Product Code: ETC6178092 | Publication Date: Sep 2024 | Updated Date: May 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Shubham Deep | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
This market segment encompasses both the development and manufacturing phases of drug production, reflecting the increasing reliance of Australia pharma firms on third-party expertise. The trend is particularly strong among small and medium enterprises that seek to navigate the complex regulatory landscape without incurring high in-house infrastructure costs.
The broader CDMO market in Australia is booming as pharmaceutical companies look to streamline operations and focus on core competencies like R&D and marketing. The demand for full-service CDMOs capable of handling complex drug formulations, regulatory compliance, and global distribution is rising. There is also a trend toward strategic partnerships and long-term collaborations, particularly in the biologics and specialty drugs segments. As the global demand for Australia-made pharmaceuticals grows, CDMOs are investing in capacity expansion and innovation.
Contract development and manufacturing organizations (CDMOs) in Australia face challenges in maintaining cost-effectiveness while meeting the highly customized needs of pharmaceutical clients. The increasing complexity of drug formulations and the need for high-quality production standards place considerable pressure on CDMOs to continuously upgrade their capabilities. There is also a risk of overcapacity in the market as smaller pharmaceutical companies demand more specialized services, leading to fierce competition. Furthermore, meeting the regulatory and compliance demands for different clients, especially in the context of new drug approval processes, remains an ongoing challenge for CDMOs.
The contract development and manufacturing organization (CDMO) market in Australia is supported by policies that encourage investment in the pharmaceutical outsourcing sector. The Australia government promotes the establishment of world-class CDMOs through incentives such as tax breaks for research and development. These policies aim to attract global pharmaceutical companies seeking to outsource their development and manufacturing needs to Australia, thereby boosting the local industry. Moreover, Australias strong intellectual property laws and access to skilled labor make it an attractive destination for CDMOs, encouraging long-term investments in the sector.
Government policies in the Contract Development and Manufacturing Organization (CDMO) market are aimed at fostering collaboration between pharmaceutical companies and contract manufacturers to enhance production efficiency and regulatory compliance. The government provides financial support for CDMOs that focus on innovation, research, and development. Policies also ensure that these organizations adhere to high-quality standards set by the TGA. The government`s role in incentivizing global partnerships and streamlining regulatory processes has allowed Australia to become an attractive destination for pharmaceutical outsourcing.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Contract Development and Manufacturing Organization Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Contract Development and Manufacturing Organization Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Contract Development and Manufacturing Organization Market - Industry Life Cycle |
3.4 Australia Contract Development and Manufacturing Organization Market - Porter's Five Forces |
3.5 Australia Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Service Type CMO, 2021 & 2031F |
3.6 Australia Contract Development and Manufacturing Organization Market Revenues & Volume Share, By Research Phase CRO, 2021 & 2031F |
4 Australia Contract Development and Manufacturing Organization Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Contract Development and Manufacturing Organization Market Trends |
6 Australia Contract Development and Manufacturing Organization Market, By Types |
6.1 Australia Contract Development and Manufacturing Organization Market, By Service Type CMO |
6.1.1 Overview and Analysis |
6.1.2 Australia Contract Development and Manufacturing Organization Market Revenues & Volume, By Service Type CMO, 2021- 2031F |
6.1.3 Australia Contract Development and Manufacturing Organization Market Revenues & Volume, By Active Pharmaceutical Ingredient (API) Manufacturing (Small Molecule, 2021- 2031F |
6.1.4 Australia Contract Development and Manufacturing Organization Market Revenues & Volume, By Large Molecule, 2021- 2031F |
6.1.5 Australia Contract Development and Manufacturing Organization Market Revenues & Volume, By High Potency (HPAPI)), 2021- 2031F |
6.1.6 Australia Contract Development and Manufacturing Organization Market Revenues & Volume, By Finished Dosage Formulation (FDF) Development, 2021- 2031F |
6.1.7 Australia Contract Development and Manufacturing Organization Market Revenues & Volume, By Manufacturing, 2021- 2031F |
6.2 Australia Contract Development and Manufacturing Organization Market, By Research Phase CRO |
6.2.1 Overview and Analysis |
6.2.2 Australia Contract Development and Manufacturing Organization Market Revenues & Volume, By Pre-Clinical, 2021- 2031F |
6.2.3 Australia Contract Development and Manufacturing Organization Market Revenues & Volume, By Phase I, 2021- 2031F |
6.2.4 Australia Contract Development and Manufacturing Organization Market Revenues & Volume, By Phase II, 2021- 2031F |
6.2.5 Australia Contract Development and Manufacturing Organization Market Revenues & Volume, By Phase III, 2021- 2031F |
6.2.6 Australia Contract Development and Manufacturing Organization Market Revenues & Volume, By Phase IV, 2021- 2031F |
7 Australia Contract Development and Manufacturing Organization Market Import-Export Trade Statistics |
7.1 Australia Contract Development and Manufacturing Organization Market Export to Major Countries |
7.2 Australia Contract Development and Manufacturing Organization Market Imports from Major Countries |
8 Australia Contract Development and Manufacturing Organization Market Key Performance Indicators |
9 Australia Contract Development and Manufacturing Organization Market - Opportunity Assessment |
9.1 Australia Contract Development and Manufacturing Organization Market Opportunity Assessment, By Service Type CMO, 2021 & 2031F |
9.2 Australia Contract Development and Manufacturing Organization Market Opportunity Assessment, By Research Phase CRO, 2021 & 2031F |
10 Australia Contract Development and Manufacturing Organization Market - Competitive Landscape |
10.1 Australia Contract Development and Manufacturing Organization Market Revenue Share, By Companies, 2024 |
10.2 Australia Contract Development and Manufacturing Organization Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |